Sorry...last post should have read 3/17...and NCL $3.6 mill..seems
AFT was certainly busy in racking up Balance Sheet debt to alarming levels
despite a poor ongoing operational /unprofitable business model
under what can only be described as perhaps incompetent historical
management...So, accumulated $3.6mill in current B/S debt...........
cannot see new management going anywhere near addressing this issue
i.e paying out... without massive CR.........
Cheers
- Forums
- ASX - By Stock
- AFT
- Ann: Appendix 4C - quarterly Dec 17
AFT
afg 2023-1 trust in respect of series 2023-1
Add to My Watchlist
0.00%
!
0.1¢

Ann: Appendix 4C - quarterly Dec 17, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.020M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AFT (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online